Evaluating the evidence for non-monotonic dose-response relationships: A systematic literature review and (re-)analysis of in vivo toxicity data in the area of food safety.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Bokkers, B G H
Boon, P E
De Wit-Bos, L
MetadataShow full item record
TitleEvaluating the evidence for non-monotonic dose-response relationships: A systematic literature review and (re-)analysis of in vivo toxicity data in the area of food safety.
Published inToxicol Appl Pharmacol 2018; 339:10-23
PubliekssamenvattingThis study aims to evaluate the evidence for the existence of non-monotonic dose-responses (NMDRs) of substances in the area of food safety. This review was performed following the systematic review methodology with the aim to identify in vivo studies published between January 2002 and February 2015 containing evidence for potential NMDRs. Inclusion and reliability criteria were defined and used to select relevant and reliable studies. A set of six checkpoints was developed to establish the likelihood that the data retrieved contained evidence for NMDR. In this review, 49 in vivo studies were identified as relevant and reliable, of which 42 were used for dose-response analysis. These studies contained 179 in vivo dose-response datasets with at least five dose groups (and a control group) as fewer doses cannot provide evidence for NMDR. These datasets were extracted and analyzed using the PROAST software package. The resulting dose-response relationships were evaluated for possible evidence of NMDRs by applying the six checkpoints. In total, 10 out of the 179 in vivo datasets fulfilled all six checkpoints. While these datasets could be considered as providing evidence for NMDR, replicated studies would still be needed to check if the results can be reproduced to rule out that the non-monotonicity was caused by incidental anomalies in that specific study. This approach, combining a systematic review with a set of checkpoints, is new and appears useful for future evaluations of the dose response datasets regarding evidence of non-monotonicity.
- Opinion on the impact of non-monotonic dose responses on EFSA's human health risk assessments.
- Authors: EFSA Scientific Committee., More S, Benford D, Hougaard Bennekou S, Bampidis V, Bragard C, Halldorsson T, Hernandez-Jerez A, Koutsoumanis K, Lambré C, Machera K, Mullins E, Nielsen SS, Schlatter J, Schrenk D, Turck D, Tarazona J, Younes M
- Issue date: 2021 Oct
- Non-monotonic dose-response relationships and endocrine disruptors: a qualitative method of assessment.
- Authors: Lagarde F, Beausoleil C, Belcher SM, Belzunces LP, Emond C, Guerbet M, Rousselle C
- Issue date: 2015 Feb 11
- Assessing dose-response relationships for endocrine disrupting chemicals (EDCs): a focus on non-monotonicity.
- Authors: Zoeller RT, Vandenberg LN
- Issue date: 2015 May 15
- Probabilistic assessment method of the non-monotonic dose-responses-Part I: Methodological approach.
- Authors: Chevillotte G, Bernard A, Varret C, Ballet P, Bodin L, Roudot AC
- Issue date: 2017 Aug
- Examining the evidence of non-monotonic dose-response in Androgen Receptor agonism high-throughput screening assay.
- Authors: Klimenko K
- Issue date: 2021 Jan 1